"The prevalence of new strains will double about every two weeks, which could lead to higher-than-expected infection rates into the spring, former head of the Food and Drug Administration Dr. Scott Gottlieb said. A faster vaccination effort will be crucial to stemming that anticipated surge, Dr. Gottlieb added."
I certainly hope Ii-key is the real deal, and that NGIO shocks the world.
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links